340B drug program was created to help patients, not boost hospital profits

Published



Enacted more than 25 years ago with bipartisan support, the 340B program was designed to help healthcare safety net providers deliver more affordable outpatient prescription drugs to vulnerable or uninsured patients.

These safety net providers include certain hospitals, such as disproportionate share hospitals, or DSH hospitals, and children’s hospitals, as well as federal grantees, such as federally qualified health centers and Ryan White HIV/AIDS clinics. Drug manufacturers provide lifesaving medicines at steep discounts to participating safety net healthcare providers, who are then expected to improve or increase care for vulnerable or uninsured patients. While federal grantees are held to a high standard and are required to report how they are using 340B to help patients, hospitals are not held to that same requirement.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.